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Abstract
Background: Helping people make well-informed decisions about dysvascular partial foot amputation is becoming
increasingly important as improvements in diabetes care and vascular surgery make more distal amputations
increasingly possible. The high rates of complications and reamputations associated with partial foot amputation
are of concern, particularly given that transtibial amputation seems to result in similar outcomes (e.g., mobility and
quality of life) with comparatively few complications and reamputations. The aim of this review is to describe the
outcomes of dysvascular partial foot amputation and compare these to transtibial amputation. Results from the
review are intended for use in the development of shared decision-making resources.
Methods/design: A comprehensive range of databases—MEDLINE, EMBASE, PsycINFO, AMED, Cumulative Index of
Nursing and Allied Health Literature (CINAHL), ProQuest Nursing and Allied Health, and Web of Science—will be
searched using National Library of Medicine, Medical Subject Headings (MeSH) terms as well as title, abstract, and
keywords relating to different amputation levels and outcomes of interest; specifically: incidence, prevalence, and
rate of amputation; rate of mortality, wound failure, dehiscence, and time between index and ipsilateral reamputations;
and mobility, functional ability, activity and participation, quality of life, pain, and psychosocial outcomes including
depression and anxiety. Articles that meet the inclusion criteria will be hand-searched for relevant citations. A forward
citation search using Google Scholar will be used to identify articles not yet indexed. Original research published in the
English language after 1 January 2000 will be included. The McMaster Critical Review Forms will be used to assess
methodological quality and identify sources of bias. Included articles will be independently appraised by two
reviewers. Data will be extracted using a spreadsheet based on the Cochrane Consumers and Communication
Review Group’s data extraction template by a primary reviewer and checked for accuracy and clarity by a second
reviewer. Findings from the review will be reported as a narrative without meta-analysis given the anticipated
heterogeneity of the literature.
Discussion: Results from the review can be used in the design of shared decision-making resources to help
inform difficult decisions about partial foot amputation.
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Background
Lower limb amputation is an all too common sequel to
advanced peripheral vascular disease and the long-term
effects of diabetes that results in a wide range of adverse
health outcomes such as impaired mobility [1, 2], chronic
pain [3], and depression [4]. These consequences of lower
limb amputation often lead to significant disability and re-
duced quality of life [5, 6]. Therefore, it is not surprising
that the decision to proceed with amputation surgery is a
difficult one, even for people facing decisions about, so-
called, minor or partial foot amputation.
Helping people make well-informed decisions about par-
tial foot amputation has become increasingly important
given that, over the last 15 years, there has been a dramatic
shift in the types of lower limb amputation performed [7–
11]. The incidence of transtibial amputation has declined
steadily since about the year 2000 [7, 12–15], and there is
some evidence that partial foot amputation has increased
proportionately [7, 10, 13]. If these trends hold true into
the future, the incidence of partial foot amputation is esti-
mated to triple across the first half of this century [7].
However, there is some uncertainty about these observa-
tions given the way different health jurisdictions and re-
searchers measure and report these data [16, 17]. For
example, counting of first-ever (index) amputation under-
estimates the number of surgeries compared to counting
all amputation procedures but may better capture the
number of people affected [16, 17]. This is particularly
problematic in people with partial foot amputation given
that one third of amputations are revised to a higher level
[18–22]. Many studies only count major amputations
(e.g., above-the-ankle) [14, 23] and under-report the inci-
dence of all lower limb amputations given that up to three
quarters of all lower limb amputations are partial foot am-
putations [7, 24].
These variations in study design cloud our under-
standing of changes in types of lower limb amputations
being performed; particularly the shift from transtibial to
partial foot amputation. A better understanding of these
changes is important to help plan for the increased
number of people living with partial foot amputation
and the specialist clinical services they require (e.g.,
wound care and high-risk foot clinics and prosthetic,
orthotic, and pedorthic services).
The shift to a more distal, partial foot amputation will
be seen by many as a significant improvement given the
assumption that a more distal amputation results in better
outcomes such as improved mobility [25], improved qual-
ity of life [26–28], and lower mortality [29–31]. However,
partial foot amputation has been associated with a signifi-
cant rate of failure and numerous complications. Between
30 and 50 % of people with partial foot amputation will
experience complications including : dehiscence, ulcer-
ation, or complete failure of the wound to heal [22, 26, 27,
32–34]. Only about 50 % of all partial foot amputations
heal with no appreciable difference based on the level of
partial foot amputation [19–22, 35, 36]. The rate of heal-
ing of partial foot amputation is only about 10 % better in
non-diabetic populations, making it difficult to conclude
that the high failure rate is simply a reflection of advanced
systemic disease [20–22]. About one third of people with
an initial partial foot amputation will require revision sur-
gery, irrespective of the level of partial foot amputation,
even toe amputation [18–22, 36, 37]. The rates of failure
and reamputation in people with partial foot amputation
are disproportionately high when you consider that more
than 80 % of all transtibial amputations heal and only
about 10 % require subsequent amputation surgery on the
same limb [36–39].
It is important to contextualize the high rates of com-
plications and reamputations given that, at the point of
amputation, people with dysvascular partial foot ampu-
tation have a very short life expectancy. About 25–40 %
of people will die within 1 year of their dysvascular par-
tial foot amputation, and the average life expectancy is
less than 2 years [20, 36, 40]. The short life expectancy
following dysvascular partial foot amputation makes it
easier to appreciate just how important it is to help
people make truly well-informed decisions about their
healthcare.
This realization has led to renewed debate about the
benefits and complications of partial foot amputation
and how outcomes compare to transtibial amputation
[41, 42]. Some authors have challenged the long-held be-
lief that the high rates of complications and reamputa-
tions associated with partial foot amputation are worth
the benefits, particularly given that key outcomes such
as mobility [1, 2] and quality of life [43–46] are compar-
able in people with partial foot and transtibial amputa-
tion. However, concerns raised by other authors suggest
that closer scrutiny of the evidence is necessary [47–49].
For example, much of the literature focuses on people
with amputations through the midfoot (e.g., transmeta-
tarsal amputation) and outcomes may be better for
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people with toe amputations [47, 48]. Similarly, some
studies report very high rates of wound healing in people
with partial foot amputation—comparable to those for
people with transtibial amputation—but it is unclear what
made some surgical and rehabilitation programs so much
more effective [32, 50]. Research seems to have been fo-
cused on outcomes related to surgery or gait with little
emphasis on participation or psychosocial outcomes.
This is of particular concern given that depression and
anxiety are common experiences. For example, people
with partial foot amputation report being fearful and
anxious about the prospect of future amputations,
which does not seem to be the case for people with
transtibial amputation [51].
A comprehensive systematic review on these topics is
important to accurately describe the outcomes of partial
foot amputation and how these compare to alternative
surgical interventions, specifically transtibial amputation.
Findings from this systematic review could support cre-
ation of shared decision-making resources [52] to help
clinicians and patients make well-informed decisions
about partial foot.
Shared decision-making is a consultative process
whereby a clinician and patient jointly participate in making
decisions about healthcare [52, 53]. It is recognized inter-
nationally as a hallmark of good clinical practice and a
more effective means of influencing decisions about health-
care treatment compared to evidence summaries, best prac-
tice statements, clinical practice guidelines, or treatment
algorithms [52]. The process of shared decision-making is
seen as particularly valuable where there is uncertainty
about the evidence for different treatment options or where
decisions may be strongly influenced by an understanding
of the potential benefits and harms or by a patient’s prefer-
ences and values [52]. As such, it may be particularly valu-
able given the uncertainties about the outcomes for
dysvascular partial foot amputation and how these compare
to alternative surgical options such as transtibial amputation.
Hence, the aims of this systematic review are to, first,
describe the outcomes of dysvascular partial foot ampu-
tation with particular reference to the:
 Incidence, prevalence, or rate of amputation
 Rate of mortality, wound failure, dehiscence or skin
breakdown (i.e., ulceration) as well as time between
index and ipsilateral reamputations
 Mobility, function, participation, quality of life, pain
(i.e., phantom or residual limb pain), and
psychosocial outcomes (i.e., depression, anxiety,
body image, self-esteem)
And second, compare the outcomes of partial foot




A number of databases will be searched individually using
the OVID platform: MEDLINE, EMBASE, PsycINFO, and
AMED. Stand-alone searches will also be conducted using
: Cumulative Index of Nursing and Allied Health Litera-
ture (CINAHL), ProQuest Nursing and Allied Health, and
Web of Science.
Where possible, these databases will be searched using
the National Library of Medicine, Medical Subject Head-
ings (MeSH) amputation as well as amputee. These
MeSH terms are consistent with the root (e.g., amputa-
tion) and hierarchical branches (e.g., amputation/statis-
tics and numerical data) commonly used to index
research involving people with lower limb amputation.
We will not employ MeSH terms related to the outcome
measures of interest given that articles are not reliably
indexed using these terms. For example, many studies
that are indexed using the MeSH term quality of life do
not actually measure that outcome. By contrast, studies
that actually measure quality of life, but use outcome
measures such as the Sickness Impact Profile, are often
not indexed using the MeSH term quality of life. MeSH
terms will be “exploded” to capture all branches of the
MeSH hierarchy given the small additional increase in
the search yield compared to a “focused” search using
relevant hierarchical branches of the MeSH tree.
A list of search terms related to the population (e.g., am-
putation level) and outcome measures (e.g., quality of life),
as well as their synonyms and acronyms, will be used in
conjunction with wildcards and Boolean operators as part
of a title, abstract, and keyword search. Given that some
databases do not provide these exact field codes, alterna-
tives will be used as necessary. For example, ProQuest
Nursing and Allied Health does not include an author
keyword field and as such, the alternative field code, iden-
tifiers (IF), will be used.
Each search strategy will be rigorously developed and
tested. Individual search terms relating to each topic will
be identified based on reading relevant systematic re-
views, original research articles as well as searching data-
bases of outcomes measures (e.g., rehabmeasures.org).
Individual search terms will be constructed, tested, and
adapted to ensure that variations in spelling, punctu-
ation, acronyms, as well as adaptations to the names of
outcomes (e.g., Prosthesis Evaluation Questionnaire is
sometimes incorrectly described as the Prosthesis Ex-
perience Questionnaire) are captured using wildcards
and proximity operators. Generic acronyms will be re-
moved from the search to improve the relevance of the
results (e.g., the acronym for the Keele Assessment of
Participation (KPA) will likely identify articles measuring
pressure in kiloPascals, kPa). These search terms will be
built into larger search strings that include parentheses,
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quotation marks, and Boolean operators to control the
logic of the search as appropriate to each database.
These search strings will be tested by comparing the
search terms to the words highlighted in the title, ab-
stract, keywords, and MeSH terms included in the re-
sults. Errors will be queried, and the search strings will
be adapted and retested as necessary. The precision and
comprehensiveness of each search strategy will be evalu-
ated by comparing the search results to a bank of known
articles on each topic. Articles included in the bank will
cover a range of journal titles and publication years.
When the search fails to identify known articles included
in the bank, the search strategy will be queried, adapted,
and retested.
Given that the authors are native English speakers and
that restriction of non-English language articles does not
seem to alter the outcome of systematic reviews and
meta-analyses [54, 55], all searchers will be limited to
the English language. Search strategies will also be lim-
ited by time (i.e., 1 January 2000 to end search date)
given that, in the decade prior to the year 2000, lower
limb amputation above the ankle was increasingly com-
mon and the relative risk of amputation was significantly
higher than has been the case since [12, 14, 15]. Treat-
ments for diabetic complications and amputation sur-
gery have also changed markedly over time with the
commonplace use of revascularization surgery prior to
amputation as an illustrative example [15]. Similarly, ad-
vances in prosthetic technology have had a dramatic
effect on the interventions provided for people with par-
tial foot and transtibial amputation (e.g., carbon fiber
ankle foot orthoses and silicone liners), and there is
some evidence of their effect on the outcomes of interest
[56, 57]. As such, it is felt that literature prior to the year
2000 will not provide the most current evidence with
which to inform answers to our research aims or subse-
quent shared decision-making resources. Some data-
bases will be further limited to the type of article to
improve precision of the yield. For example, ProQuest
Nursing and Allied Health will be limited to “peer
reviewed articles” given that the database also indexes
magazine and trade journals among other literature.
In keeping with the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) guide-
lines [58], an illustrative search is presented for one
database (Table 1). Similarly, detailed searchers will be
constructed for each outcome and database included in
the review.
Reference lists of articles that meet the inclusion cri-
teria will be hand-searched to ensure that relevant publi-
cations have not been overlooked.
Given the significant lag between publication of early
online articles and indexation in databases such as MED-
LINE, we will conduct a forward citation search using
articles that meet the inclusion criteria. We will perform
the forward citation search using Google Scholar given
that the proprietary algorithm does not rely on indexation
in any database. The use of Google Scholar to search the
Table 1 Example search for the CINAHL database to identify quality of life literature for people with dysvascular partial foot and
transtibial amputation
Search Field code Search term(s)
1. MH “Amputation”
2. MH “Amputees”
3. TI, AB, SU (amput* AND (major OR lowerlimb* OR “lower limb”* OR “lower extremit*” OR “limb loss” OR LEA OR LLA))
4. TI, AB, SU (amput* AND (transtibial OR “trans tibial” OR belowknee OR “below knee” OR (below W2 knee) OR TTA OR BKA))
5. TI, AB, SU (amput* AND (minor OR “partial foot” OR Chopart* OR Lisfranc* OR tarsometatarsal OR transmetatarsal OR midtarsal OR
“mid tarsal” OR midfoot OR “mid foot” OR ray OR phalangeal OR metatarsophalangeal OR toe* OR transtarsal OR
“trans tarsal” OR TMT OR TMA OR MTP OR PFA))
6. 1 OR 2 OR 3 OR 4 OR 5
7. TI, AB, SU SF 36 OR SF36 OR “Medical Outcome* Study Short Form*” OR “Medical Outcome* Study Short-Form*” OR “MOS SF 36”
OR “MOS SF36” OR “Sickness Impact Profile*” OR “SIP” ((“Trinity Amputation and Prosthe* Experience”) W1 (Survey OR Scale*))
OR TAPES OR “Prosthe* Evaluation Questionnaire” OR PEQ OR “WHO QOL BREF” OR “WHO QOLBREF” OR “WHOQOLBREF” OR
((WHO OR “World Health Organi#ation”) W1 (“Quality of Life BREF” OR “Quality of Life Scale”)) OR “RAND36” OR “RAND 36” OR
“Orthotic*and Prosthetic* User* Survey” OR OPUS OR ((“Health Related”) W1 “Quality of Life”) OR HRQOL OR “Life Satisfaction
Questionnaire* 9” OR “LiSat 9” OR “Satisfaction With Life Scale” OR SWLS OR “Quality of Well Being” OR QWB* OR “Quality of
Life Index” OR QLI OR “EuroQOL*” OR “Euro QOL” OR EQ5D OR “EQ 5D” OR “Assessment of Quality of Life” OR AQoL OR
(Orthotic* W2 “prosthetic* user* survey”) OR “Attitude to Artificial Limb* Questionnaire” OR AALQ
8 6 AND 7
9. Limit 8 to English language
10. Limit 9 to publication date: 01.01.2000 to 31.12.2015
11. Limit 10 to peer reviewed, academic journals
Field codes: MH exact major and minor subject headings (MeSH, National Library of Medicine Medical Subject Headings), TI title, AB abstract, SU subject
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literature not indexed elsewhere is an increasingly accepted
practice to augment traditional database searches [59–61].
Data management
Results from each database search will be exported dir-
ectly into a shared online library in EndNote X7.2.1
(Thomson Reuters Inc.). Using the “find duplicates” fea-
ture in EndNote, duplicate records will be checked and
deleted. Hand-searching the EndNote records for dupli-
cates will also be undertaken given that small differences
in the bibliographic information (e.g., inclusion of a mid-
dle initial in the authors’ name) often means that dupli-
cates will not be automatically detected. Full-text copies
of articles will be sourced using the “find full text” fea-
ture in EndNote or manually retrieved (e.g., through
interlibrary loan services). Where articles are manually
retrieved, electronic versions will be subsequently linked
to the relevant EndNote record.
EndNote records will then be exported into a Microsoft
Excel spreadsheet using a custom-made EndNote output
style. The EndNote output style will allow key biblio-
graphic information about each reference (i.e., EndNote
reference number, authors, title, year, journal title, volume,
issue, page, and abstract) to be exported in a tab delimited
format such that it can be opened in Excel. The resulting
Excel spreadsheet will include each article on a single row
and separate columns for the bibliographic information.
Additional columns will be added to allow decisions
about inclusion/exclusion to be recorded, reasons for
exclusion, and to record information about the number
of full-text articles inspected. The same spreadsheet will
be expanded for data extraction and to record details of
the critical appraisal of each article as detailed in later
sections of the protocol.
To record details necessary for completion of the
PRISMA flowchart, a separate tab in the Excel spreadsheet
will be used to record details about the number of articles
retrieved from each database, duplicates removed, records
screened based on title and abstract or full-text, as well as
the number of additional records retrieved from hand-
searching and forward citation searches.
Selection process
The following criteria will be used to determine inclusion:
1. Peer reviewed studies of original research
2. Studies published in the English language
3. Studies published since 1 January 2000
4. For the first aim—describe outcomes of dysvascular
partial foot amputation—studies must include discrete
cohort(s) with dysvascular partial foot amputation
(with or without diabetes), acknowledging that some
studies will include subgroups with different levels of
partial foot amputation
5. For the second aim—compare outcomes of
dysvascular partial foot and transtibial
amputation—studies must include discrete cohorts
with dysvascular partial foot amputation and
transtibial amputation (with or without diabetes).
6. Studies that measure the outcome(s) of interest,
specifically:
(a) Incidence, prevalence, or rate of amputation
(b)Rate of mortality, wound failure, dehiscence or
skin breakdown (i.e., ulceration) as well as time
between index and ipsilateral reamputations
(c)Mobility, functional ability, participation, quality
of life, pain, or psychosocial outcomes
It is anticipated that the operational definitions and
time points of these outcomes will vary across studies.
As such, studies that meet these criteria will be included
irrespective of how the outcome has been defined or the
time point at which it was measured. By way of example,
studies reporting the rate of mortality will be included
irrespective of the time point at which the outcome was
measured (e.g., 1, 3, or 5 years post amputation). Given
that some of the outcomes are not so readily defined, we
include the following definitions. For the purposes of this
review, mobility is defined as the ability to move inde-
pendently from one place to another [62, 63]. By virtue of
this definition, outcomes focusing on distance and time,
or those that decompose movement into discrete subtasks
(e.g., sit to stand), will be included along with community
measures of mobility that reflect the potential impairment
that results from environmental barriers common to many
day-to-day mobility tasks in the community. Participation
is defined as involvement in all areas of life [64] and
thereby includes outcomes that capture involvement in
a broad range of life situations such as family roles,
self-care needs, social activities, work, and education.
Functional ability is defined as the skill to perform ac-
tivities [63]—typically activities of daily living, such as
self-care—and the degree to which difficulty limits in-
dependence with these activities. Psychological out-
comes of interest include depression, anxiety, body
image, and self-esteem given publications highlighting
these experiences among people with partial foot am-
putation [51, 65]. Similarly, measures of phantom and
residual limb pain will also be recorded.
By virtue of the inclusion criteria, studies with a het-
erogeneous sample of different amputation levels (e.g.,
all above-the-ankle amputations) or causes (e.g., trauma
and peripheral vascular disease) will be excluded. While
editorials, letters, conference abstracts, and opinion
pieces will be excluded, there will be no other restric-
tions regarding study design.
Definitions of transtibial and partial foot amputation
will be consistent with the International Standards
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Organization (ISO) definitions [66] and as such all levels
of partial foot amputation, including toe amputation, will
be included. By virtue of the ISO definition, ankle disar-
ticulation (i.e., Syme amputation) is not considered a
partial foot amputation and as such, studies focused on
this level of amputation will be excluded.
Search results will be screened by one investigator
based on review of the title and abstract. In cases where
insufficient detail is reported in the abstract, the full-text
article will be retrieved. Given that the inclusion criteria
are unambiguous and do not require complex judgment,
it will be unnecessary to routinely involve two investiga-
tors in the screening process [67]. On occasion, a second
opinion may be sought from another investigator and
any disagreement will be resolved through discussion
until consensus. Following screening based on title and
abstract, full-text articles will be retrieved and independ-
ently reviewed by two investigators to confirm inclusion.
Quality appraisal/risk of bias in individual studies
We will use the McMaster Critical Review Forms [68, 69]
to assess methodological quality and identify sources of
bias in included articles. The McMaster Critical Review
Forms are one of the few appraisal tools appropriate for
use with a wide variety of study designs [70] and include
structured guidelines to reduce the likelihood of errors
with use [71]. The McMaster Critical Review Forms
meet acceptable standards for content and initial
construct validity as well as inter-rater and test re-test
reliability [72]. Results from the quality appraisal will
be reported in tabular format using Microsoft Excel
and include detailed comments to support the checklist
items, as illustrated in Table 2.
Data extraction
A data extraction spreadsheet will be developed in Micro-
soft Excel based on the Cochrane Consumers and Commu-
nication Review Group’s data extraction template to allow
socio-demographic (e.g., age, sex, etiology, level of amputa-
tion, comorbidities), methodological (e.g., aim, study de-
sign, recruitment method, inclusion criteria), results
(e.g., outcome measures), and quality appraisal details
(using checklist items and comments) to be systematic-
ally recorded [73]. The layout of the spreadsheet and
the included fields will be based on previous systematic
reviews that included people with partial foot or transtibial
amputation, similar outcome measures, and quality ap-
praisal tools [45, 57, 74]. In keeping with recommenda-
tions to reduce error rates and omissions and improve
reliability of data extraction, column headings will include
intuitive acronyms, units of measurement, and fields for
comments. For example, comments embedded in the col-
umn headings for the critical appraisal checklist items will
include the actual question and decision rules so that re-
viewers can “scroll-over” the column heading for these de-
tails. Where possible, pull-down menus will be used to
Table 2 Example table showing results of a quality appraisal for two quality of life (QoL) studies using the McMaster Critical Review
Form for quantitative studies [45]
Aim +
background
Study design Sample Outcomes Intervention Results Conclusion
Study A B C D E F G H I J K L M N O P
Boutoille et al. [46] Case-control 34 Y Y Y
25-9a
Reviewer comments: Unclear description of aim and background. New results were presented in the discussion. QoL in the
partial foot and transtibial amputee cohorts were compared to non-amputee cohort with foot ulceration but not to each other.
Detailed sample demographic information was not provided. Co-intervention: the foot ulcer group was receiving active treatment
while the amputee group had completed rehabilitation. Power bias present in assessment of capacity for inclusion, as the participants’
doctor decided if they were able to complete the survey. High risk of type-1 error due to multiple t tests employed. Large variability
in the results, making it difficult to detect meaningful differences.
Peters et al. [43] Y Y Case-control 124 Y Y Y Y Y
35-89a
Reviewer comments: Control bias: the case and control groups were significantly different in terms of: gender, duration of
diabetes, and degree of neuropathy. QoL assessed with Sickness Impact Profile, focusing on functional status. Data pooled for
persons with transtibial and transfemoral amputations (high level) and all levels of partial foot amputation (mid-level). A large
variability in the results makes it difficult to detect meaningful differences. High chance of a Type 1 error given between group
comparisons of multiple dependent variables.
Quality assessment items from McMaster University Critical Review Form—quantitative studies are listed as per the following key: A: Was the study purpose stated
clearly?; B: Was relevant background literature reviewed?; C: Study design; D: Sample size (n) and the number of cases versus controls as applicable; E: Was the
sample described in detail?; F: Was sample size justified?; G: Were the outcome measures reliable?; H: Were the outcome measures valid?; I: Was intervention
described in detail?; J: Was contamination avoided?; K: Was co-intervention avoided?; L: Were results reported in terms of statistical significance?; M: Were the
analysis method(s) appropriate?; N: Was clinical importance reported?; O: Were dropouts reported?; P: Were conclusions appropriate given study methods and
results? Note: For clarity, only questions with affirmative responses have been shown
aNumber of cases versus controls
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standardize data entry (e.g., list of study designs) and cod-
ing (e.g., yes/no/unclear/not reported/not applicable).
Prior to implementation, the data extraction spreadsheet
will be piloted and refined. A number of articles covering
the range of topics will be appraised by each of the re-
viewers and data extracted. Adaptations to the spreadsheet
will be made in response to feedback on the pilot.
Included articles will be independently appraised by
two reviewers with good knowledge of the content area
and experience in conducting systematic reviews, includ-
ing the process of data extraction and verification. Data
will be extracted by a primary reviewer and checked for
accuracy and clarity by a second reviewer. Given the
scope of the review, single data extraction with inde-
pendent verification is preferred to duplicate data extrac-
tion given the significant time saving (average 50 min
per article) [75] and that both approaches result in very
similar error rates (single extraction 17 %; double extrac-
tion 14.5 %) [75] that have been shown to be inconse-
quential to the final outcome [75, 76]. Disagreements or
inconsistencies in the data extraction or critical appraisal
will be resolved through discussion until consensus. As
necessary, a third reviewer will be called upon to also
appraise the article and contribute to the consensus de-
cision. Authors of the original research will be contacted
for additional information or to clarify aspects of the
method design as deemed necessary.
Where data for the same participants has been reported
across multiple studies, subject numbers, demographics,
and outcomes will be compared for discrepancies. If there
is uncertainty about the similarity of the study partici-
pants and results, authors of the original research will
be contacted for clarification. Where data for the same
subjects is reported across multiple studies, reference
will be made to all the studies but data will be treated
as a single source.
Data summary and reporting
Findings from the review will be reported as a narrative
without meta-analysis given that previous reviews in-
volving people with partial foot amputation [42, 45, 57]
suggest that there will be few studies on each outcome
and these will be heterogeneous in terms of study de-
sign, outcome measures used, and subjects included,
thus making meta-analysis inappropriate. As an illustra-
tive example, a recent quality of life review [45] found
just two case-controlled studies reporting data in people
with partial foot amputation and transtibial amputation
(Table 2). Each study used a different outcome measure,
and details about the participants’ sex or the presence of
comorbidities were not adequately reported, which made
it difficult to assess the degree to which participants
were similar across these studies (Table 2). This illustra-
tive example typifies much of the literature involving
people with limb loss and highlights why narrative re-
views have been widely used [45, 57, 77].
In this review, the result narratives will be presented by
topic (e.g., mobility) and the literature characterized in
terms of study designs, subject characteristics, and out-
come measures used. Studies will also be characterized in
terms of their quality/risk of bias using the findings of the
critical appraisal. Common issues with internal and exter-
nal validity will be discussed with a specific focus on limita-
tions that lead to imprecision, indirectness, inconsistency,
and publication bias [78]. The extent to which these issues
impact the results will be discussed and lead to an under-
standing about which studies engender the most confi-
dence in the results and why. Where possible, results will
be reported with a breakdown by level of partial foot am-
putation and comparisons to the outcomes of people with
transtibial amputation will be made.
Discussion
Evidence for shared decision-making resources
We hope that by critically apprising and synthesizing
evidence on the outcomes of partial foot amputation, we
will be able to include information in future shared
decision-making resources that is consistent with a well-
informed interpretation of the current research evidence.
In this way, the shared decision-making resources we
create can help people engage in meaningful and often
difficult discussions about dysvascular partial foot ampu-
tation given uncertainties about the outcomes and how
these compare to alternative surgical options such as
transtibial amputation.
Method design considerations
There are a number of considerations that influence the
design of the protocol for this systematic review that are
important to acknowledge. The protocol was deliberately
designed to address the primary aim of the review, that
is, to describe the outcomes of dysvascular partial foot
amputation. While the secondary aim is to compare out-
comes between people with dysvascular partial foot and
transtibial amputation, it is important to realize that it is
largely cohort studies, not randomized control trials,
that will provide the most appropriate evidence to in-
form this aim, as it would be unethical to randomize
people to receive either a partial foot or transtibial am-
putation given that such decisions are highly influenced
by a patient’s preferences and values [52]. It should come
as no surprise that we do not expect any randomized
control trials will be included in this review. By logical
extension, the risk of bias in individual studies as well as
confidence in the cumulative evidence cannot be judged
by criteria suited to randomized control trials. As such,
we hope readers appreciate our approach to assessing
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the risk of bias as well as describing the strength of the
body of the evidence using a narrative approach.
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